DESERT MOUNTAIN ENERGY CORP (DME.CA) Stock Fundamental Analysis

TSX-V:DME • CA25043D1078

0.24 CAD
+0.01 (+4.35%)
Last: Feb 23, 2026, 07:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to DME. DME was compared to 802 industry peers in the Metals & Mining industry. The financial health of DME is average, but there are quite some concerns on its profitability. DME has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year DME has reported negative net income.
  • In the past year DME has reported a negative cash flow from operations.
  • DME had negative earnings in each of the past 5 years.
  • DME had a negative operating cash flow in each of the past 5 years.
DME.CA Yearly Net Income VS EBIT VS OCF VS FCFDME.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of DME (-9.15%) is better than 62.09% of its industry peers.
  • Looking at the Return On Equity, with a value of -9.80%, DME is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
Industry RankSector Rank
ROA -9.15%
ROE -9.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DME.CA Yearly ROA, ROE, ROICDME.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • DME does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DME.CA Yearly Profit, Operating, Gross MarginsDME.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

6

2. Health

2.1 Basic Checks

  • DME does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for DME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DME.CA Yearly Shares OutstandingDME.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
DME.CA Yearly Total Debt VS Total AssetsDME.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

  • DME has an Altman-Z score of 2.35. This is not the best score and indicates that DME is in the grey zone with still only limited risk for bankruptcy at the moment.
  • DME has a Altman-Z score (2.35) which is comparable to the rest of the industry.
  • DME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.35
ROIC/WACCN/A
WACC10.56%
DME.CA Yearly LT Debt VS Equity VS FCFDME.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • DME has a Current Ratio of 2.00. This is a normal value and indicates that DME is financially healthy and should not expect problems in meeting its short term obligations.
  • DME has a Current ratio (2.00) which is comparable to the rest of the industry.
  • A Quick Ratio of 2.00 indicates that DME should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.00, DME is in line with its industry, outperforming 52.99% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 2
DME.CA Yearly Current Assets VS Current LiabilitesDME.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.08% over the past year.
  • The Revenue for DME has decreased by -50.66% in the past year. This is quite bad
EPS 1Y (TTM)63.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-50.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.12%

3.2 Future

  • Based on estimates for the next years, DME will show a very strong growth in Earnings Per Share. The EPS will grow by 73.21% on average per year.
  • DME is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 256.37% yearly.
EPS Next Y60%
EPS Next 2Y73.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year310%
Revenue Next 2Y256.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

DME.CA Yearly Revenue VS EstimatesDME.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
DME.CA Yearly EPS VS EstimatesDME.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.02 -0.02 0.04 -0.04 -0.06

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DME. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 4.66 indicates a rather cheap valuation of DME.
  • 98.00% of the companies in the same industry are more expensive than DME, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.75, DME is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.66
DME.CA Price Earnings VS Forward Price EarningsDME.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DME.CA Per share dataDME.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

  • DME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DME's earnings are expected to grow with 73.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.21%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • DME does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DESERT MOUNTAIN ENERGY CORP

TSX-V:DME (2/23/2026, 7:00:00 PM)

0.24

+0.01 (+4.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)01-28
Earnings (Next)03-04
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.71%
Ins Owner ChangeN/A
Market Cap23.05M
Revenue(TTM)860.30K
Net Income(TTM)-4.58M
Analysts84.44
Price Target0.51 (112.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-85.34%
Min Revenue beat(2)-94.84%
Max Revenue beat(2)-75.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.66
P/S 26.79
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0.05
Fwd EY21.46%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.01
BVpS0.49
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.15%
ROE -9.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -27696.2%
Cap/Sales 170.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2
Quick Ratio 2
Altman-Z 2.35
F-Score3
WACC10.56%
ROIC/WACCN/A
Cap/Depr(3y)5568.56%
Cap/Depr(5y)38613%
Cap/Sales(3y)1760.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y60%
EPS Next 2Y73.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.12%
Revenue Next Year310%
Revenue Next 2Y256.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.32%
OCF growth 3YN/A
OCF growth 5YN/A

DESERT MOUNTAIN ENERGY CORP / DME.CA FAQ

Can you provide the ChartMill fundamental rating for DESERT MOUNTAIN ENERGY CORP?

ChartMill assigns a fundamental rating of 3 / 10 to DME.CA.


What is the valuation status for DME stock?

ChartMill assigns a valuation rating of 4 / 10 to DESERT MOUNTAIN ENERGY CORP (DME.CA). This can be considered as Fairly Valued.


What is the profitability of DME stock?

DESERT MOUNTAIN ENERGY CORP (DME.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for DME stock?

The financial health rating of DESERT MOUNTAIN ENERGY CORP (DME.CA) is 6 / 10.


What is the earnings growth outlook for DESERT MOUNTAIN ENERGY CORP?

The Earnings per Share (EPS) of DESERT MOUNTAIN ENERGY CORP (DME.CA) is expected to grow by 60% in the next year.